Home
The Department of Biomedicine

News archive for The Department of Biomedicine

A state-of-the-art imaging system for high-throughput crystallization experiments has been installed at BiSS at the Department of Biomedicine. The system is capable of imaging samples using both visible and UV light. The imager is a significant addition to the crystallization laboratory as well as BiSS, providing a seamless workflow from the Mosquito LCP pipetting robot to automated imaging. It... Read more
Bergen Medical Research Foundation (BFS) has announced to award funding for 4-years to Professor Arvid Lundervold for his project „Computational Medical Imaging and Machine Learning».
The Workshop in Applied Structural Bioinformatics will be organized at the University of Bergen October 16-20. This workshop will provide a practical introduction to popular tools for biomolecular visualisation, analysis and simulations. Lectures will be given by both international and local speakers from the research fields of structural bioinformatics and computer-aided drug design.
In November 2017, the University of Bergen hosted the second annual meeting and winter school for members of the Innovative Training Network "switchBoard"
The Department of Biomedicine is glad to welcome the research group lead by Thomas Arnesen, who is currently moving into their new offices and laboratories.
Ina Katrine Nitschke Pettersen defends her dissertation “A study of cellular metabolic flexibility under energy stress”
Development of novel anticancer and cardioprotective agents that target prohibitins and the translation initiation factor eIF4a
The Shank family of proteins functions as a molecular scaffold in the neuronal post-synaptic density, enabling numerous protein-protein interactions. Shanks are large multi-domain molecules, and one of the conserved domains is an SH3 domain. Using high-resolution X-ray crystallography, we show that the SH3 domain in the Shank family has lost its canonical ligand-binding site.
The research group around Karl Johan Tronstad at the Department of Biomedicine has been granted 9.5 million to investigate the causes of chronic fatigue syndrome, or myalgic encephalopathy CFS/ME.
PhD-candidate Pugazendhi Murugan Erusappan will defend his thesis: “Molecular Aspects of Integrin α11 Function”
Sarsia Seed recently announced their new seed funds in Bergen consisting of 300 million NOK. Initial investment can be in the biotechnology company Pluvia founded by Prof. Aurora Martinez according to Sarsia officials.
Open for registration, deadline 20th of February.
Interesting meeting in Molecular Imaging in Cologne, Germany, 05-07.04.2017

Pages